ReviewJournal of gastroenterology2007
Effects of eradication of Helicobacter pylori on gastric carcinogenesis in experimental models.
Review in Journal of gastroenterology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Vonoprazan-Based Regimen Is More Useful than PPI-Based One as a First-LineCanadian journal of gastroenterology & hepatology · 2017Trial
- Murine Models of Gastric Corpus Preneoplasia.Cellular and molecular gastroenterology and hepatology · 2017Review
- Short-term Intervention to Revert Premalignant Lesions as Strategy to Prevent Gastrointestinal Cancers.Journal of cancer prevention · 2013Review
- Youngest case of an early gastric cancer after successful eradication therapy.World journal of gastrointestinal endoscopy · 2013Article
- Prevention of Gastric Cancer: When is Treatment of Helicobacter Pylori Warranted?Therapeutic advances in gastroenterology · 2008Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Helicobacter pylori infection enhances glandular stomach carcinogenesis in Mongolian gerbils (MGs) treated with N-methyl-N'-nitro-N-nitrosoguanidine and N-methyl-N-nitrosourea. A high-salt diet has been revealed to synergistically enhance development of stomach cancer with H. pylori infection; the latter exerts stronger promoting effects than the former. Eradication of H. pylori with antibiotics diminishes their enhancing effects. The earlier the eradication of H. pylori is undergone, the more effective is the prevention of gastric carcinogenesis in MGs. To explore whether the role of H. pylori infection is a cause of stomach carcinogenesis (initiator) or just a supporting actor (promoter), we established an experimental model of long-term (2 years) H. pylori infection and eradication in MGs without chemical carcinogens. Long-term H. pylori infection stimulated development of highly proliferative and dilated glands containing a large amount of mucin, called heterotopic proliferative glands (HPGs), resembling mucinous adenocarcinomas. However, no gastric carcinomas were found in MGs after 2 years of H. pylori infection in our system. After eradication of the bacteria, HPGs were obviously reduced, and gastric lesions were mostly alleviated. These findings showed that H. pylori infection is related to severe gastritis and that HPGs are frequently induced reversible lesions rather than being malignant in character. Helicobacter pylori infection thus appears to have a strong promotional influence but not to initiate gastric carcinogenesis.
Indexed as
Identifiers
17238018What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.